Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Hasford

Showing results (11-20 of 103) with videos related to

Pageof 11
Sort By:
Family Practice|March 1, 1991
Medical students knowledge of HIV infection and AIDS. Members of the Association of University Teachers in General PracticeM M Kochen, J Hasford
The European Respiratory Journal|November 1, 2006
Excess mortality in patients with asthma on long-acting beta2-agonistsJ Hasford, J C Virchow
International Journal of Clinical Pharmacology and Therapeutics|September 16, 2004
Safety and usage pattern of low-dose diclofenac when used as an over-the-counter medication: results of an observational cohort study in a community-based pharmacy settingJ Hasford, N Moore, K Hoye
Therapie|September 1, 1993
CART and logistic regression analyses of risk factors for first dose hypotension by an ACE-inhibitorJ Hasford, H Ansari, K Lehmann
Pharmacoepidemiology and Drug Safety|April 10, 2004
Adverse drug reaction monitoring--cost and benefit considerations. Part I: frequency of adverse drug reactions causing hospital admissionsN Muehlberger, S Schneeweiss, J Hasford
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|October 22, 2011
[Hospital admission due to adverse drug events (ADE): an analysis of German routine hospital data of 2006]C Amann, J Hasford, J Stausberg
Leukemia|April 30, 2005
How long will chronic myeloid leukemia patients treated with imatinib mesylate live?J Hasford, M Pfirrmann, A Hochhaus
Pharmacoepidemiology and Drug Safety|April 10, 2004
Drug use assessment and risk evaluation in pregnancy--the PEGASUS-projectC Irl, P Kipferler, J Hasford, et al.
Pharmacoepidemiology and Drug Safety|April 10, 2004
Adverse drug reaction monitoring--cost and benefit considerations. Part II: cost and preventability of adverse drug reactions leading to hospital admissionM Goettler, S Schneeweiss, J Hasford
Zeitschrift Fur Gerontologie Und Geriatrie|October 14, 2006
[Psychopharmacological drug treatment in Munich nursing homes]E Molter-Bock, J Hasford, T Pfundstein
Pageof 11

Showing results (11-20 of 103) with videos related to

Sort By:
Pageof 11
Family Practice|March 1, 1991
Medical students knowledge of HIV infection and AIDS. Members of the Association of University Teachers in General PracticeM M Kochen, J Hasford
The European Respiratory Journal|November 1, 2006
Excess mortality in patients with asthma on long-acting beta2-agonistsJ Hasford, J C Virchow
International Journal of Clinical Pharmacology and Therapeutics|September 16, 2004
Safety and usage pattern of low-dose diclofenac when used as an over-the-counter medication: results of an observational cohort study in a community-based pharmacy settingJ Hasford, N Moore, K Hoye
Therapie|September 1, 1993
CART and logistic regression analyses of risk factors for first dose hypotension by an ACE-inhibitorJ Hasford, H Ansari, K Lehmann
Pharmacoepidemiology and Drug Safety|April 10, 2004
Adverse drug reaction monitoring--cost and benefit considerations. Part I: frequency of adverse drug reactions causing hospital admissionsN Muehlberger, S Schneeweiss, J Hasford
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|October 22, 2011
[Hospital admission due to adverse drug events (ADE): an analysis of German routine hospital data of 2006]C Amann, J Hasford, J Stausberg
Leukemia|April 30, 2005
How long will chronic myeloid leukemia patients treated with imatinib mesylate live?J Hasford, M Pfirrmann, A Hochhaus
Pharmacoepidemiology and Drug Safety|April 10, 2004
Drug use assessment and risk evaluation in pregnancy--the PEGASUS-projectC Irl, P Kipferler, J Hasford, et al.
Pharmacoepidemiology and Drug Safety|April 10, 2004
Adverse drug reaction monitoring--cost and benefit considerations. Part II: cost and preventability of adverse drug reactions leading to hospital admissionM Goettler, S Schneeweiss, J Hasford
Zeitschrift Fur Gerontologie Und Geriatrie|October 14, 2006
[Psychopharmacological drug treatment in Munich nursing homes]E Molter-Bock, J Hasford, T Pfundstein
Pageof 11